3Diao J, Gorczyski R M, Cattral M. Regulatory role of CD200 on dendritic cells[J]. FASEB J,2002; 16(5) :226-267.
4Gorczyski R M, Lee L, Boudakav Iet al. Augnaented induction of CD4 + CD25 + Treg using monoclonal antibodies to CD20OR[ J]. Transplantation, 2005 ; 79:488-491.
5Nakao S, Feng X, Sugimori C. Immune pathophysiology of aplastic[J]. Int J Hematol, 2005 ; 82 (3) : 196-200.
7Dubey S, Shukla P, Nityanand S et al. Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia[J]. Ann Hematol, 2005; 84 (9) : 572-577.
2Giannakoulas NC, Karakantza M, Theodorou GL,et al. Clinical relevance of balance between type 1 and type 2 immune responses of lymphocyte subpopulations in aplastic anaemia patients. Br J Haematol,2004,124(1):97-105.
3Dubey S, Shukla P, Nityanand S. Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia.Ann Hematol,2005,84(9):572-577.
4Hara T, Ando K, Tsurumi H, et al. Excessive production of tumor necrosis factor alpha by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemia. Eur J Haematol,2004,73(1):10-16.
5Demeter J, Messer G, Schrezenmeier H. Clinical relevance of the TNF alpha promoter/enhancer polymorphism in patients with aplastic anemia. Ann Hematol, 2002,81 (10) : 566-569.
6Dufour C, Capasso M, Svahn J,et al.Homozygosis for (12) CA repeats in the first intron of the human IFN-gamma gene is significantly associated with the risk of aplastic anaemia in Caucasian population. Br J Haematot, 2004,126( 5 ) : 682-685.
7Pravica V, Asderakis A, Perrey C, et al. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gammagene. Eur J Immunogenet, 1999,26(1):1-3.
8Dufour C, Corcione A, Svahn J, et al. Interferon gamma and tumnur necrosis factor alpha are overexpressed in bone marrow T lymphoeytes from paediatric patients with aplastic anaemia. Br J Haematol,2001,115(4): 1023-1031.
9Dirksen U, Moghadam KA, Mambetova C,et al. Glutathione S transferase theta 1 gene (GSTT1) null genotype is associated with an increased risk for acquired aplastic anemia in children. Pediatr Res,2004,55(3):466-471.
10Fogarty PF, Yamaguchi H, Wiestner A,et al. Late presentation of dyskeratosis congenita as apparently acquired aplastic anacmia due to mutations in telomerase RNA. Lancet, 2003, 362(9396):1628-1630.
6Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood, 2006, 108 (8) : 2509 -2519.
7Hu X, Gu Y, Wang Y, et al. Increased CIM + and CD8 + effector memory T ceils in patients with aplastic anemia. Haematologica, 2009 , 94 ( 3 ) : 428 - 429.
8Zeng W, Kajigaya S, Chen G, et al. Transcript profile of CD4 + and CD8 + T cells from the bone marrow of acquired aplastic anemia pa- tients. Exp Hematol, 2004, 52(9): 806-814.
9Sa Q, Woodward J, Suzuki Y. IL-2 produced by CD8 + immune T cells can augment their IFN-γ production independently from their proliferation in the secondary response to an intracellular pathogen. J Immunol, 2013,190(5): 2199-2207.
10Liu Z, Liu JQ, Talebian F, et al. IL-27 enhances the survival of tumor antigen-specific CD8 + T ceils and programs them into IL-10- producing, memory precursor-like effector cells. Eur J Immunol, 2013, 43(2) :468 -479.
